« Previous AbstractDetermination of exposure of dispensary drug preparers to cyclophosphamide by passive sampling and liquid chromatography with tandem mass spectrometry    Next AbstractEffects of sex pheromones and sexual maturation on locomotor activity in female sea lamprey (Petromyzon marinus) »

J Oncol Pharm Pract

Title:		Development of a closed drug preparation method for oral anticancer drugs
Author(s):		Wakui N; Ookubo T; Iwasaki Y; Ito R; Saito K; Nakazawa H;
Address:		"Department of Analytical Chemistry, Hoshi University, Japan; Department of Pharmacy, Kawasaki Municipal Kawasaki Hospital, Japan"
Journal Title:		J Oncol Pharm Pract
Year:		2013
Volume:		20130104
Issue:		4
Page Number:		315 - 320
DOI:		10.1177/1078155212467554
ISSN/ISBN:		1477-092X (Electronic) 1078-1552 (Linking)
Abstract:		"The objective of this article is to reduce the preparation time for oral anticancer drugs, reduce the exposure to drug preparations, and develop drug preparation equipment without external drug leaks in a closed state. In the newly developed closed oral drug preparation device, a 10 mL disposable syringe that was replaced with one projection for crushing tablets and a no-processing 30 mL disposable syringe were connected to a three-way stopcock. Using this instrument, Endoxan((R)) tablets (principal components: cyclophosphamide) were crushed and suspended in water in a closed state. The drug was prepared to suspension and flowed out via a feeding tube by switching the handle of the three-way stopcock. To assess human exposure to cyclophosphamide, a high-performance volatile organic compound-solvent desorption passive sampler was attached to the preparer's mouth to collect air drifting in the vicinity, and cyclophosphamide levels were subsequently measured by liquid chromatography with tandem mass spectrometry. Using the developed drug preparation equipment, Endoxan((R)) tablets were suspended in a closed state. According to liquid chromatography with tandem mass spectrometry analysis, the exposure of the preparer to cyclophosphamide was greatly reduced when using the developed device; cyclophosphamide was detected in only two of the five samples, though only at trace levels. The closed oral drug preparation device may permit the preparation and administration of toxic drugs to patients while greatly reducing the risk of occupational exposure among health-care workers and caregivers"
Keywords:		"Administration, Oral Antineoplastic Agents/analysis/chemistry Antineoplastic Agents, Alkylating/analysis/*chemistry Chromatography, Liquid Cyclophosphamide/analysis/*chemistry Drug Compounding/instrumentation/*methods Environmental Monitoring/methods Equi;"
Notes:		"MedlineWakui, Nobuyuki Ookubo, Tetuo Iwasaki, Yusuke Ito, Rie Saito, Koichi Nakazawa, Hiroyuki eng England 2013/01/08 J Oncol Pharm Pract. 2013 Dec; 19(4):315-20. doi: 10.1177/1078155212467554. Epub 2013 Jan 4"